TY  - CHAP
M1  - Book, Section
TI  - Antiarrhythmic Drugs
A1  - Katzung, Bertram G.
A1  - Kruidering-Hall, Marieke
A1  - Tuan, Rupa Lalchandani
A1  - Vanderah, Todd W.
A1  - Trevor, Anthony J.
Y1  - 2021
N1  - 
T2  - Katzung & Trevor's Pharmacology: Examination & Board Review, 13e
AB  - Cardiac  arrhythmias  are  the  most  common  cause  of  death  in  patients  with  a  myocardial  infarction  or  terminal  heart  failure.  They  increase  in  prevalence  in  the  elderly  and  atrial  fibrillation  is  particularly  common  in  this  group.  Arrhythmias  are  also  the  most  serious  manifestation  of  digitalis  toxicity  and  are  often  associated  with  anesthetic  procedures,  hyperthyroidism,  and  electrolyte  disorders.  The  drugs  used  for  arrhythmias  fall  into  five  major  groups  or  classes,  but  most  have  very  low  therapeutic  indices  and  when  feasible,  nondrug  therapies  (cardioversion,  pacemakers,  ablation,  implanted  defibrillators)  are  used.  In  addition,  conditions  associated  with  certain  arrhythmias,  especially  increased  risk  of  thromboembolism  in  atrial  fibrillation,  must  be  treated  with  appropriate  drugs  from  other  groups  (eg,  anticoagulants).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1180555736
ER  -